A key vaccine panel at the Centers for Disease Control and Prevention voted 8-3 to nix a recommendation that all newborns be given a first dose of hepatitis B vaccine
NegativeU.S News
- A key vaccine panel at the Centers for Disease Control and Prevention (CDC) voted 8-3 to discontinue the recommendation that all newborns receive a first dose of the hepatitis B vaccine. This decision marks a significant shift in public health policy, overturning decades of guidance that aimed to prevent infections and liver cancer in infants.
- The reversal of this recommendation raises concerns among health officials and advocates about the potential increase in hepatitis B infections among newborns, particularly in vulnerable populations. The decision could limit access to this preventive measure for many families, especially those from lower-income backgrounds.
- This development reflects ongoing debates within the CDC regarding vaccination policies and public health strategies. The decision comes amid heightened scrutiny of vaccine recommendations and the influence of political pressures, which have sparked discussions about the reliability of health information and the implications for public trust in vaccination programs.
— via World Pulse Now AI Editorial System
